Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.98
+0.13002.22%
Pre-market: 5.90-0.0800-1.34%04:55 EDT
Volume:683.83K
Turnover:4.06M
Market Cap:341.15M
PE:-5.34
High:6.00
Open:5.80
Low:5.79
Close:5.85
52wk High:7.65
52wk Low:4.00
Shares:57.05M
Float Shares:36.92M
Volume Ratio:0.77
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1200
EPS(LYR):1.01
ROE:-43.13%
ROA:-24.55%
PB:2.66
PE(LYR):5.92

Loading ...

Abeona Therapeutics Management to Present at H.C. Wainwright Global Investment Conference

Reuters
·
17 mins ago

Abeona Therapeutics Sees Major Insider Move From Company Director

TIPRANKS
·
9 hours ago

Abeona Therapeutics Director Mark Alvino Disposes of 15,000 Common Shares Worth $87,966

Reuters
·
13 hours ago

Abeona Therapeutics Grants 13,300 Restricted Shares to Five New Hires Under NASDAQ Inducement Plan

Reuters
·
Yesterday

Abeona Therapeutics® Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Yesterday

High Insider Ownership Growth Stocks To Watch In August 2026

Simply Wall St.
·
Aug 22

Abeona Therapeutics reports Q2 EPS (35c), consensus (25c)

TIPRANKS
·
Aug 17

Abeona Therapeutics is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 15

Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating

MT Newswires Live
·
Aug 14

Abeona Therapeutics, Inc. : Oppenheimer Cuts Target Price to $21 from $22

THOMSON REUTERS
·
Aug 14

CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Abeona Therapeutics Down Nearly 15%, on Pace for Largest Percent Decrease Since April 2024

Dow Jones
·
Aug 13

Abeona Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Abeona Shares Fall on Swing to 2Q Loss, Lower-than-Expected Revenue

Dow Jones
·
Aug 13

MeiraGTx Q2 Revenue Jumps on Reogen License Revenue

Reuters
·
Aug 13

Abeona Therapeutics Falls After Quarterly Loss, Revenue Miss

Reuters
·
Aug 13

Abeona Therapeutics Q2 Net Loss Widens, Misses Analyst Expectations

Reuters
·
Aug 13

Abeona Therapeutics Q2 EPS $(0.35) Misses $(0.23) Estimate, Sales $11.380M Miss $12.239M Estimate

Benzinga Earnings
·
Aug 13

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

THOMSON REUTERS
·
Aug 13